HA
HC Advisors’s ALX Oncology ALXO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.51K | Sell |
20,500
-1,000
| -5% | -$415 | 0.01% | 59 |
|
|
2025
Q1 | $13.4K | Buy |
21,500
+6,025
| +39% | +$3.75K | 0.01% | 61 |
|
|
2024
Q4 | $25.8K | Sell |
15,475
-300
| -2% | -$501 | 0.02% | 58 |
|
|
2024
Q3 | $28.7K | Buy |
+15,775
| New | +$28.7K | 0.02% | 52 |
|
|
2022
Q4 | – | Sell |
-13,933
| Closed | -$133K | – | 87 |
|
|
2022
Q3 | $133K | Sell |
13,933
-190
| -1% | -$1.81K | 0.09% | 80 |
|
|
2022
Q2 | $114K | Buy |
14,123
+333
| +2% | +$2.69K | 0.08% | 76 |
|
|
2022
Q1 | $233K | Sell |
13,790
-4,202
| -23% | -$71K | 0.15% | 77 |
|
|
2021
Q4 | $387K | Buy |
17,992
+9,786
| +119% | +$210K | 0.24% | 53 |
|
|
2021
Q3 | $606K | Sell |
8,206
-572
| -7% | -$42.2K | 0.4% | 38 |
|
|
2021
Q2 | $480K | Sell |
8,778
-167
| -2% | -$9.13K | 0.3% | 46 |
|
|
2021
Q1 | $660K | Sell |
8,945
-858
| -9% | -$63.3K | 0.43% | 37 |
|
|
2020
Q4 | $845K | Buy |
9,803
+3,300
| +51% | +$284K | 0.58% | 30 |
|
|
2020
Q3 | $245K | Buy |
+6,503
| New | +$245K | 0.2% | 58 |
|